Healx is a Cambridge, UK-based company passionate about finding new therapeutic solutions for rare diseases. The company uses advanced data analytics, including machine learning and modern computational biology techniques to identify novel drug applications in the area of rare disorders.

Their unique model places patient advocacy groups at the heart of the drug discovery process, leading the way to personalized medicine for rare diseases.

Listed in 2017 as a ‘Leading Global Innovator’ in Disrupt 100 and awarded ‘Cambridge Graduate Startup of the Year’ in 2016, Healx is considered as one of the leading startups of the Cambridge cluster.

Amadeus contact

Hermann Hauser